Search clinical trials for: Rituximab CHOP chemotherapy

Total 6023 results

European Lung Cancer Working Party

Completed

Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer

Non Small Cell Lung Carcinoma

Belgium
Shenzhen People's Hospital

Unknown

Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer (BINC-B)

Breast Neoplasms

China
Fundació Institut de Recerca de l'Hospital de la...

Withdrawn

Integral Attention Program With or Without Palliative Chemotherapy in Advanced Cancer Patients (PAI)

Cancer

Spain
Università Vita-Salute San Raffaele

Completed

Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection

Locally Advanced Pancreatic Adenocarcinoma

Italy
Chinese University of Hong Kong

Completed

Intermittent Versus Continuous Tarceva Study

Metastatic Colorectal Cancer

Hong Kong
National Cancer Institute (NCI)

Completed

Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial

Neoplasm Metastasis | Breast Neoplasm

United States
University Hospital Carl Gustav Carus
Technische Universität Dresden

Unknown

Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET

Hodgkin Disease

Germany
Zhao Chong
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Jiangxi... and other collaborators

Completed

Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial

Local Advanced High Risk Nasopharyngeal Carcinoma

China
Region Örebro County

Recruiting

Hot Water Immersion After Myocardial Infarction (HOT-MI)

Cardiac Rehabilitation | Cardiac Disease

Sweden
Vrije Universiteit Brussel

Recruiting

The Effects of Schema Therapy in Outpatient Forensic Mental Health Care: a Single Case Multiple-baseline Study. (STOFSCED)

Personality Disorders

Belgium
University College, London

Completed

The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)

Thrombotic Thrombocytopenic Purpura (TTP)

United Kingdom
University Hospital, Geneva

Active, not recruiting

A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-Lymphoma (FRILLY)

Aggressive B-Cell Non-Hodgkin Lymphoma

Switzerland
Jean M. Tersak, M.D.
Genentech, Inc.

Terminated

Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma

Neuroblastoma | Opsoclonus-myoclonus
Institut fuer anwendungsorientierte Forschung und...
German High-Grade Non-Hodgkin's Lymphoma Study Group; University Hospital Goettingen

Completed

Allo-hNHL (FluBuCy)

Non-Hodgkin's Lymphoma

Germany
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Unknown

Pharmacokinetics, Efficacy and Safety of the 304 Injection

CD20 Positive B Cell NHL

China
Hoffmann-La Roche

Completed

A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET)

Rheumatoid Arthritis

Sweden, Canada
Hoffmann-La Roche

Completed

A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)

Non-Hodgkin's Lymphoma

Italy
Stanford University
Genentech and Biogen IDEC

Completed

Rituximab for Pediatric Renal Transplant Rejection

Kidney Transplantation

United States
International Extranodal Lymphoma Study Group (IELSG)

Completed

Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma

Lymphoma, Mucosa-Associated Lymphoid Tissue

United Kingdom, France, Italy, Switzerland, Spain, Belgium
Assistance Publique - Hôpitaux de Paris
Hoffmann-La Roche

Completed

Rituximab in Auto-Immune Hemolytic Anemia (RAHIA)

Warm Autoimmune Hemolytic Anemia

France
German High-Grade Non-Hodgkin's Lymphoma Study...

Completed

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

Lymphoma

Germany, Switzerland
Swiss Group for Clinical Cancer Research

Completed

Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL

Leukemia

Switzerland
Rigshospitalet, Denmark
Copenhagen University Hospital at Herlev

Unknown

Electrochemotherapy on Head and Neck Cancer

Head Neck Cancer

Denmark
Cancer Institute and Hospital, Chinese Academy...

Unknown

A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.

Gastric Cancer

China
Hospital San Carlos, Madrid
Asociación de Afectados Por Tumores Cerebrales en España (ASATE)

Recruiting

Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma (GLINERA)

Glioblastoma | Glioblastoma Multiforme | Radiotherapy; Complications | Glioblastoma, IDH-wildtype | Cancer Brain

Spain
Second Affiliated Hospital, School of Medicine,...

Recruiting

A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma

Osteosarcoma

China
Sun Yat-sen University

Not yet recruiting

CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy

Nasopharyngeal Carcinoma
SCRI Development Innovations, LLC
Genentech, Inc.

Terminated

Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma

Primary Central Nervous System Lymphoma

United States
Consorci Sanitari de Terrassa

Recruiting

Trimodality Treatment in Bladder Cancer

Urinary Bladder Neoplasms | Bladder Cancer | Bladder Disease

Spain
Fujian Cancer Hospital

Not yet recruiting

Second-line Surufatinib Combined With Chemotherapy in Advanced CRC

Advanced Colorectal Cancer
Tang-Du Hospital

Completed

Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer

Sintilimab and Anlotinib in Combination With Chemotherapy

China
Dr Kundan Singh Chufal

Active, not recruiting

Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning (QARC)

Esophageal Neoplasm

Australia, India
Nohla Therapeutics, Inc.

Terminated

NLA101 in Adults Receiving High Dose Chemotherapy for AML (LAUNCH)

Leukemia, Myeloid, Acute

United States, Korea, Republic of, Australia
Yonsei University

Completed

Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy

Advanced-stage Ovarian Cancer

Korea, Republic of
American Regent, Inc.

Completed

Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma

Malignant Melanoma

United States
Chinese University of Hong Kong

Completed

PET-CT and Circulating Tumor Cells in Colorectal Cancer

Colorectal Cancer | Metastasis

Hong Kong
University of Virginia

Withdrawn

A Prospective Trial of COXEN Chemotherapy Prediction

Ovarian Neoplasms | Fallopian Tube Neoplasms
Innovent Biologics (Suzhou) Co. Ltd.

Withdrawn

IBI397 or Combination Therapies in Patients With Advanced Malignancies

Advanced Malignancies

China
Celltrion

Completed

PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis (rituximab)

Rheumatoid Arthritis
Shandong University
The Affiliated Hospital of Qingdao University; Yantai Yuhuangding Hospital

Unknown

Rituximab Combining Bortezomib Versus Rituximab in Management of ITP

Purpura, Thrombocytopenic, Idiopathic | Immune Thrombocytopenia

China
Biocad

Completed

Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma

Splenic Marginal Zone Lymphoma | Nodal Marginal Zone Lymphoma | Follicular Non-Hodgkin's Lymphoma

India, Russian Federation, Colombia, South Africa, Ukraine
Sanjiv Sam Gambhir

Withdrawn

Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT

Non-Hodgkin's Lymphoma

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

Lymphoma

United States
DEKK-TEC, Inc.
National Cancer Institute (NCI); The University of Texas Health Science Center... and other collaborators

Completed

Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors (DM-CHOC-PEN)

Metastatic Malignant Neoplasm to Brain | Primary Brain Tumors

United States
National Cancer Institute (NCI)

Recruiting

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

Lymphoplasmacytic Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Grade 3b Follicular... and other conditions

United States
Samsung Medical Center

Completed

Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity

Nocturia

Korea, Republic of
Istituto Giannina Gaslini
Bambino Gesù Hospital and Research Institute

Recruiting

Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Idiopathic Nephrotic Syndrome. (RTXvsMMF)

Nephrotic Syndrome Steroid-Dependent

Italy
Hoffmann-La Roche

Completed

A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

France
Millennium Pharmaceuticals, Inc.

Completed

VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma

Follicular Lymphoma | B-Cell Lymphoma | Marginal Lymphoma

United States
3D Medicines (Sichuan) Co., Ltd.

Recruiting

Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC

Non-small Cell Lung Cancer

China

Search clinical trials for: Rituximab CHOP chemotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations